Challenges for biomarker discovery in body fluids using SELDI-TOF-MS

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  De Bock, Muriel ^a   De Seny, Dominique ^a   Meuwis, Marie Alice ^a   Chapelle, Jean Paul ^a   Louis, Edouard ^a   Malaise, Michel ^a   Merville, Marie Paule ^a   Fillet, Marianne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUID; DATA ANALYSIS; HUMAN; MEDICAL TECHNOLOGY; METHODOLOGY; PATIENT INFORMATION; PLASMA; REVIEW; SALIVA ANALYSIS; SAMPLE; SAMPLE SIZE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; CHEMISTRY; MASS SPECTROMETRY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; BODY FLUIDS; HUMANS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77449131580     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/906082     Document Type: Review

References (137)

1. L. A. Liotta, M. Ferrari, and E. Petricoin, "Clinical pro-teomics: written in blood," Nature, vol. 425, no. 6961, p. 905, 2003.
2. A. D. Westont and L. Hood, "Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine," Journal of Proteome Research, vol. 3, no. 2, pp. 179-196, 2004. (Pubitemid 38500984)
3. A. Gorg, W. Weiss, and M. J. Dunn, "Current two-dimensional electrophoresis technology for proteomics," Proteomics, vol. 4, no. 12, pp. 3665-3685, 2004. (Pubitemid 39657447)
4. G. Mitulovic, C. Stingl, M. Smoluch, et al., "Automated, online two-dimensional nano liquid chromatography tandem mass spectrometry for rapid analysis of complex protein digests," Proteomics, vol. 4, no. 9, pp. 2545-2557, 2004. (Pubitemid 39202156)
5. R. S. Tirumalai, K. C. Chan, D. A. Prieto, H. J. Issaq, T. P. Conrads, and T. D. Veenstra, "Characterization of the low molecular weight human serum proteome," Molecular & Cellular Proteomics, vol. 2, no. 10, pp. 1096-1103, 2003.
6. G. L. Wright Jr., "SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis," Expert Review of Molecular Diagnostics, vol. 2, no. 6, pp. 549-563, 2002. (Pubitemid 35387847)
7. T. Hutchens and T. Yip, "New desorption strategies for the mass spectrometric analysis of macromolecules," Rapid Commun Mass Spectrom, vol. 7, pp. 576-580, 1993.
8. G. L. Wright Jr., L. H. Cazares, S.-M. Leung, et al., "ProteinChip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures," Prostate Cancer and Prostatic Diseases, vol. 2, no. 5-6, pp. 264-276, 1999. (Pubitemid 30252204)
9. N. Tang, P. Tornatore, and S. R. Weinberger, "Current developments in SELDI affinity technology," Mass Spectrometry Reviews, vol. 23, no. 1, pp. 34-44, 2004.
10. M. Abramovitz and B. Leyland-Jones, "A systems approach to clinical oncology: focus on breast cancer," Proteome Science, vol. 4, p. 5, 2006.
11. F. Bertucci, D. Birnbaum, and A. Goncalves, "Proteomics of breast cancer: principles and potential clinical applications," Molecular and Cellular Proteomics, vol. 5, no. 10, pp. 1772-1786, 2006. (Pubitemid 44688187)
12. F. Bertucci and A. Goncalves, "Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery," Future Oncology, vol. 4, no. 2, pp. 271-287, 2008. (Pubitemid 351715784)
13. J. A. P. Bons, M. P. van Dieijen-Visser, and W. K. W. H. Wodzig, "Clinical proteomics in chronic inflammatory diseases: a review," Proteomics Clinical Applications, vol. 1, no. 9, pp. 1123-1133, 2007.
14. C. S. Buhimschi, V. Bhandari, B. D. Hamar, et al., "Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis," PLoS Medicine, vol. 4, no. 1, article e18, 2007.
15. I. A. Buhimschi, E. Zambrano, C. M. Pettker, et al., "Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis," Obstetrics and Gynecology, vol. 111, no. 2, part 1, pp. 403-412, 2008. (Pubitemid 351653432)
16. I. A. Buhimschi, G. Zhao, V. A. Rosenberg, S. Abdel-Razeq, S. Thung, and C. S. Buhimschi, "Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth," PLoS ONE, vol. 3, no. 4, article e2049, 2008.
17. C. H. Clarke, J. A. Buckley, and E. T. Fung, "SELDI-TOF-MS proteomics of breast cancer," Clinical Chemistry and Laboratory Medicine, vol. 43, no. 12, pp. 1314-1320, 2005.
18. D. de Seny, M. Fillet, M.-A. Meuwis, et al., "Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteinchip approach," Arthritis and Rheumatism, vol. 52, no. 12, pp. 3801-3812, 2005. (Pubitemid 41798218)
19. D. de Seny, M. Fillet, C. Ribbens, et al., "Monomeric cal-granulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis," Clinical Chemistry, vol. 54, no. 6, pp. 1066-1075, 2008. (Pubitemid 351793415)
20. J. He, J. Gornbein, D. Shen, et al., "Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry," International Journal of Oncology, vol. 30, no. 1, pp. 145-154, 2007.
21. M. Hellstrom, H. Lexander, B. Franzen, and L. Egevad, "Proteomics in prostate cancer research," Analytical and Quantitative Cytology and Histology, vol. 29, no. 1, pp. 32-40, 2007. (Pubitemid 46333519)
22. A. Hodgetts, M. Levin, J. S. Kroll, and P. R. Langford, "Biomarker discovery in infectious diseases using SELDI," Future Microbiology, vol. 2, no. 1, pp. 35-49, 2007. (Pubitemid 46766997)
23. J. T.-J. Huang, L. Wang, S. Prabakaran, et al., "Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues," Molecular Psychiatry, vol. 13, no. 12, pp. 1118-1128, 2008.
24. S. Hundt, U. Haug, and H. Brenner, "Blood markers for early detection of colorectal cancer: a systematic review," Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 10, pp. 1935-1953, 2007. (Pubitemid 47621167)
25. K. K. Jain, "Recent advances in clinical oncoproteomics," Journal of Buon, vol. 12, supplement 1, pp. S31-S38, 2007. (Pubitemid 350200859)
26. Y. Mao, J. Yu, J. Chen, et al., "Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis," Transplant Immunology, vol. 18, no. 3, pp. 255-259, 2008. (Pubitemid 350161850)
27. R. Martinez-Pinna, J. L. Martin-Ventura, S. Mas, L. M. Blanco-Colio, J. Tunon, and J. Egido, "Proteomics in atherosclerosis," Current Atherosclerosis Reports, vol. 10, no. 3, pp. 209-215, 2008.
28. M.-A. Meuwis, M. Fillet, P. Geurts, et al., "Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling," Biochemical Pharmacology, vol. 73, no. 9, pp. 1422-1433, 2007. (Pubitemid 46469959)
29. M.-A. Meuwis, M. Fillet, L. Lutteri, et al., "Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study," Clinical Biochemistry, vol. 41, no. 12, pp. 960-967, 2008.
30. S. J. Pitteri and S. M. Hanash, "Proteomic approaches for cancer biomarker discovery in plasma," Expert Review of Proteomics, vol. 4, no. 5, pp. 589-590, 2007. (Pubitemid 47623428)
31. E. R. Sauter, S. Shan, J. E. Hewett, P. Speckman, and G. C. Du Bois, "Proteomic analysis of nipple aspirate fluid using SELDl-TOF-MS," International Journal of Cancer, vol. 114, no. 5, pp. 791-796, 2005. (Pubitemid 40344440)
32. Y. Shen, J. Kim, E. F. Strittmatter, et al., "Characterization of the human blood plasma proteome," Proteomics, vol. 5, no. 15, pp. 4034-4045, 2005. (Pubitemid 41502498)
33. A. H. Simonsen, J. McGuire, V. N. Podust, et al., "Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease," Neurobiology of Aging, vol. 29, no. 7, pp. 961-968, 2008. (Pubitemid 351697984)
34. N. Tomosugi, K. Kitagawa, N. Takahashi, S. Sugai, and I. Ishikawat, "Diagnostic potential of tear proteomic patterns in Sjogren's syndrome," Journal of Proteome Research, vol. 4, no. 3, pp. 820-825, 2005. (Pubitemid 40863270)
35. H. Zetterberg, U. Rüetschi, E. Portelius, et al., "Clinical pro-teomics in neurodegenerative disorders," Acta Neurologica Scandinavica, vol. 118, no. 1, pp. 1-11, 2008.
36. J. Y. M. N. Engwegen, N. Mehra, J. B. A. G. Haanen, et al., "Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations," Laboratory Investigation, vol. 87, no. 2, pp. 161-172, 2007.
37. D. M. Good, V. Thongboonkerd, J. Novak, et al., "Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future," Journal of Proteome Research, vol. 6, no. 12, pp. 4549-4555, 2007.
38. M. Kiehntopf, R. Siegmund, and T. Deufel, "Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations," Clinical Chemistry and Laboratory Medicine, vol. 45, no. 11, pp. 1435-1449, 2007. (Pubitemid 350036581)
39. D. McLerran, W. E. Grizzle, Z. Feng, et al., "Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias," Clinical Chemistry, vol. 54, no. 1, pp. 44-52, 2008. (Pubitemid 351182595)
40. D. McLerran, W. E. Grizzle, Z. Feng, et al., "SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer," Clinical Chemistry, vol. 54, no. 1, pp. 53-60, 2008. (Pubitemid 351182596)
41. A. Villar-Garea, M. Griese, and A. Imhof, "Biomarker discovery from body fluids using mass spectrometry," Journal of Chromatography B, vol. 849, no. 1-2, pp. 105-114, 2007. (Pubitemid 46529308)
42. P. Maurya, P. Meleady, P. Dowling, and M. Clynes, "Pro-teomic approaches for serum biomarker discovery in cancer," Anticancer Research, vol. 27, no. 3A, pp. 1247-1255, 2007. (Pubitemid 46807270)
43. T. L. Nickolas, J. Barasch, and P. Devarajan, "Biomarkers in acute and chronic kidney disease," Current Opinion in Nephrology and Hypertension, vol. 17, no. 2, pp. 127-132, 2008. (Pubitemid 351253035)
44. L. C. Whelan, K. A. R. Power, D. T. McDowell, J. Kennedy, and W. M. Gallagher, "Applications of SELDI-MS technology in oncology," Journal of Cellular and Molecular Medicine, vol. 12, no. 5, pp. 1535-1547, 2008.
45. P. Findeisen and M. Neumaier, "Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective," Clinical Chemistry and Laboratory Medicine, vol. 47, no. 6, pp. 666-684, 2009.
46. R. Apweiler, C. Aslanidis, T. Deufel, et al., "Approaching clinical proteomics: current state and future fields of application in fluid proteomics," Clinical Chemistry and Laboratory Medicine, vol. 47, no. 6, pp. 724-744, 2009.
47. J. Albrethsen, R. Bogebo, J. Olsen, H. Raskov, and S. Gam-meltoft, "Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum," Clinical Chemistry and Laboratory Medicine, vol. 44, no. 10, pp. 1243-1252, 2006. (Pubitemid 44580807)
48. R. E. Banks, A. J. Stanley, D. A. Cairns, et al., "Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry," Clinical Chemistry, vol. 51, no. 9, pp. 1637-1649, 2005. (Pubitemid 41233099)
49. S. Barelli, D. Crettaz, L. Thadikkaran, O. Rubin, and J.-D. Tissot, "Plasma/serum proteomics: pre-analytical issues," Expert Review of Proteomics, vol. 4, no. 3, pp. 363-370, 2007. (Pubitemid 46890073)
50. M. Dijkstra, R. J. Vonk, and R. C. Jansen, "SELDI-TOF mass spectra: a view on sources of variation," Journal of Chromatography B, vol. 847, no. 1, pp. 12-23, 2007. (Pubitemid 46216202)
51. G. L. Hortin, "Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?" Clinical Chemistry, vol. 51, no. 1, pp. 3-5, 2005. (Pubitemid 40024002)
52. J. N. Mcguire, J. Overgaard, and F. Pociot, "Mass spectrom-etry is only one piece of the puzzle in clinical proteomics," Briefings in Functional Genomics and Proteomics, vol. 7, no. 1, pp. 74-83, 2008. (Pubitemid 351721152)
53. H. Mischak, R. Apweiler, R. E. Banks, et al., "Clinical proteomics: a need to define the field and to begin to set adequate standards," Proteomics Clinical Applications, vol. 1, no. 2, pp. 148-156, 2007.
54. M. Papale, M. C. Pedicillo, B. J. Thatcher, et al., "Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis," Journal of Chromatography B, vol. 856, no. 1-2, pp. 205-213, 2007. (Pubitemid 47307442)
55. T. C. W. Poon, "Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices," Expert Review of Proteomics, vol. 4, no. 1, pp. 51-65, 2007. (Pubitemid 46239472)
56. A. J. Rai, C. A. Gelfand, B. C. Haywood, et al., "HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples," Proteomics, vol. 5, no. 13, pp. 3262-3277, 2005. (Pubitemid 41192034)
57. A. J. Rai, P. M. Stemmer, Z. Zhang, et al., "Analysis of human proteome organization plasma proteome project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers," Proteomics, vol. 5, no. 13, pp. 3467-3474, 2005. (Pubitemid 41192051)
58. A. J. Rai and F. Vitzthum, "Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics," Expert Review of Proteomics, vol. 3, no. 4, pp. 409-426, 2006. (Pubitemid 44231984)
59. D. Rollin, T. Whistler, and S. D. Vernon, "Laboratory methods to improve SELDI peak detection and quantitation," Proteome Science, vol. 5, p. 9, 2007.
60. R. Schipper, A. Loof, J. de Groot, L. Harthoorn, E. Dransfield, and W. van Heerde, "SELDI-TOF-MS of saliva: methodology and pre-treatment effects," Journal of Chromatography B, vol. 847, no. 1, pp. 45-53, 2007. (Pubitemid 46216200)
61. J. F. Timms, E. Arslan-Low, A. Gentry-Maharaj, et al., "Preanalytic influence of sample handling on SELDI-TOF serum protein profiles," Clinical Chemistry, vol. 53, no. 4, pp. 645-656, 2007. (Pubitemid 46580234)
62. C. N. White, Z. Zhang, and D. W. Chan, "Quality control for SELDI analysis," Clinical Chemistry and Laboratory Medicine, vol. 43, no. 2, pp. 125-126, 2005. (Pubitemid 40361456)
63. O. J. Semmes, Z. Feng, B.-L. Adam, et al., "Evaluation of serum protein profiling by surface-enhanced laser des-orption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility," Clinical Chemistry, vol. 51, no. 1, pp. 102-112, 2005. (Pubitemid 40024018)
64. K. A. Baggerly, J. S. Morris, and K. R. Coombes, "Repro-ducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments," Bioinformatics, vol. 20, no. 5, pp. 777-785, 2004. (Pubitemid 38443834)
65. J. Hu, K. R. Coombes, J. S. Morris, and K. A. Baggerly, "The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales," Briefings in Functional Genomics and Proteomics, vol. 3, no. 4, pp. 322-331, 2005. (Pubitemid 40468216)
66. J. Hu, K. R. Coombes, J. S. Morris, and K. A. Baggerly, "The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales," Briefings in Functional Genomics and Proteomics, vol. 3, no. 4, pp. 322-331, 2005. (Pubitemid 40468216)
67. S.-Y. Hsieh, R.-K. Chen, Y.-H. Pan, and H.-L. Lee, "Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling," Proteomics, vol. 6, no. 10, pp. 3189-3198, 2006. (Pubitemid 43806414)
68. C. E. L. Dammann, M. Meyer, O. Dammann, and N. von Neuhoff, "Protein detection in dried blood by surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS)," Biology of the Neonate, vol. 89, no. 2, pp. 126-132, 2006. (Pubitemid 43254168)
69. F. H. Grus, V. N. Podust, K. Bruns, et al., "SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye," Investigative Ophthalmology and Visual Science, vol. 46, no. 3, pp. 863-876, 2005. (Pubitemid 41321022)
70. S. Hu, J. A. Loo, and D. T. Wong, "Human body fluid proteome analysis," Proteomics, vol. 6, no. 23, pp. 6326-6353, 2006. (Pubitemid 44935518)
71. J. L. Noble, R. S. Dua, G. R. Coulton, C. M. Isacke, and G. P. H. Gui, "A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer," European Journal of Cancer, vol. 43, no. 16, pp. 2315-2320, 2007. (Pubitemid 47625974)
72. E. O'Riordan, T. N. Orlova, V. N. Podust, et al., "Characterization of urinary peptide biomarkers of acute rejection in renal allografts," American Journal of Transplantation, vol. 7, no. 4, pp. 930-940, 2007. (Pubitemid 46481208)
73. M. Papale, M. C. Pedicillo, S. Di Paolo, et al., "Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis," Clinical Chemistry and Laboratory Medicine, vol. 46, no. 1, pp. 89-99, 2008.
74. R. Schipper, A. Loof, J. de Groot, L. Harthoorn, W. van Heerde, and E. Dransfield, "Salivary protein/peptide profiling with SELDI-TOF-MS," Annals of the New York Academy of Sciences, vol. 1098, pp. 498-503, 2007. (Pubitemid 47092531)
75. F. J. Schweigert, B. Gericke, W. Wolfram, U. Kaisers, and J. W. Dudenhausen, "Peptide and protein profiles in serum and follicular fluid of women undergoing IVF," Human Reproduction, vol. 21, no. 11, pp. 2960-2968, 2006. (Pubitemid 44567013)
76. K. S. Shores and D. R. Knapp, "Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis," Journal of Proteome Research, vol. 6, no. 9, pp. 3739-3751, 2007. (Pubitemid 47522762)
77. M. Suzuki, G. F. Ross, K. Wiers, et al., "Identification of a urinary proteomic signature for lupus nephritis in children," Pediatric Nephrology, vol. 22, no. 12, pp. 2047-2057, 2007. (Pubitemid 350090711)
78. A. Goncalves, E. Charafe-Jauffret, F. Bertucci, et al., "Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes," Molecular and Cellular Proteomics, vol. 7, no. 8, pp. 1420-1433, 2008.
79. C. Jansen, K. M. Hebeda, M. Linkels, et al., "Protein profiling of B-cell lymphomas using tissue biopsies: a potential tool for small samples in pathology," Cellular Oncology, vol. 30, no. 1, pp. 27-38, 2008. (Pubitemid 351161035)
80. S. Schaub, J. Wilkins, T. Weiler, K. Sangster, D. Rush, and P. Nickerson, "Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrome-try," Kidney International, vol. 65, no. 1, pp. 323-332, 2004. (Pubitemid 38037520)
81. H. Tammen, I. Schulte, R. Hess, et al., "Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display," Proteomics, vol. 5, no. 13, pp. 3414-3422, 2005. (Pubitemid 41192047)
82. A. Z. Traum, M. P. Wells, M. Aivado, T. A. Libermann, M. F. Ramoni, and A. D. Schachter, "SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions," Proteomics, vol. 6, no. 5, pp. 1676-1680, 2006.
83. J. Yi, C. Kim, and C. A. Gelfand, "Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma," Journal of Proteome Research, vol. 6, no. 5, pp. 1768-1781, 2007. (Pubitemid 46814501)
84. A. E. Pelzer, I. Feuerstein, C. Fuchsberger, et al., "Influence of blood sampling on protein profiling and pattern analysis using matrix-assisted laser desorption/ionisation mass spec-trometry," BJU International, vol. 99, no. 3, pp. 658-662, 2007. (Pubitemid 46238846)
85. J. L. Luque-Garcia and T. A. Neubert, "Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry," Journal of Chromatography A, vol. 1153, no. 1-2, pp. 259-276, 2007. (Pubitemid 46755182)
86. M. Battino, M. S. Ferreiro, I. Gallardo, H. N. Newman, and P. Bullon, "The antioxidant capacity of saliva," Journal of Clinical Periodontology, vol. 29, no. 3, pp. 189-194, 2002. (Pubitemid 41697851)
87. H. Voorbij, "Pouten en risiko's in een klinisch-chemisch laboratorium," Nederlands Tijdschrift voor Klinische Chemie, vol. 19, pp. 36-41, 1994.
88. A. Gagnon, Q. Shi, and B. Ye, "Surface-enhanced laser desorption/ionization mass spectrometry for protein and peptide profiling of body fluids," Methods in Molecular Biology, vol. 441, pp. 41-56, 2008.
89. G. MacGregor, R. D. Gray, T. N. Hilliard, et al., "Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid," Journal of Cystic Fibrosis, vol. 7, no. 5, pp. 352-358, 2008.
90. J. T.-J. Huang, L. Wang, S. Prabakaran, et al., "Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues," Molecular Psychiatry, vol. 13, no. 12, pp. 1118-1128, 2008.
91. N. L. Anderson and N. G. Anderson, "The human plasma proteome: history, character, and diagnostic prospects," Molecular & Cellular Proteomics, vol. 1, no. 11, pp. 845-867, 2002.
92. M. A. Gillette, D. R. Mani, and S. A. Carr, "Place of pattern in proteomic biomarker discovery," Journal of Proteome Research, vol. 4, no. 4, pp. 1143-1154, 2005. (Pubitemid 41208673)
93. M. K. D. R. Dayarathna, W. S. Hancock, and M. Hincapie, "A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: application to the analysis of obesity, diabetes, and hypertension diseases," Journal of Separation Science, vol. 31, no. 6-7, pp. 1156-1166, 2008. (Pubitemid 351649844)
94. X. Jiang, M. Ye, and H. Zou, "Technologies and methods for sample pretreatment in efficient proteome and peptidome analysis," Proteomics, vol. 8, no. 4, pp. 686-705, 2008. (Pubitemid 351362930)
95. P. Matt, Z. Fu, Q. Fu, and J. E. Van Eyk, "Biomarker discovery: proteome fractionation and separation in biological samples," Physiological Genomics, vol. 33, no. 1, pp. 12-17, 2008. (Pubitemid 351451369)
96. M. Pernemalm, L. M. Orre, J. Lengqvist, et al., "Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery," Journal of Pro-teome Research, vol. 7, no. 7, pp. 2712-2722, 2008.
97. P. G. Righetti, E. Boschetti, L. Lomas, and A. Citterio, "Protein equalizer technology: the quest for a "democratic proteome"," Proteomics, vol. 6, no. 14, pp. 3980-3992, 2006.
98. K. S. Shores, D. G. Udugamasooriya, T. Kodadek, and D. R. Knapp, "Use of peptide analogue diversity library beads for increased depth of proteomic analysis: application to cerebrospinal fluid," Journal of Proteome Research, vol. 7, no. 5, pp. 1922-1931, 2008.
99. C. Sihlbom, I. Kanmert, H. V. Bahr, and P. Davidsson, "Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins," Journal of Proteome Research, vol. 7, no. 9, pp. 4191-4198, 2008.
100. S. W. Tam, J. Pirro, and D. Hinerfeld, "Depletion and fractionation technologies in plasma proteomic analysis," Expert Review of Proteomics, vol. 1, no. 4, pp. 411-420, 2004. (Pubitemid 43826408)
101. J. R. Whiteaker, H. Zhang, J. K. Eng, et al., "Head-to-head comparison of serum fractionation techniques," Journal of Proteome Research, vol. 6, no. 2, pp. 828-836, 2007. (Pubitemid 46340186)
102. F. E. Ahmed, "Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry," Journal of Separation Science, vol. 32, no. 5-6, pp. 771-798, 2009.
103. N. Zolotarjova, P. Mrozinski, H. Chen, and J. Martosella, "Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum," Journal of Chromatography A, vol. 1189, no. 1-2, pp. 332-338, 2008.
104. M. Pernemalm, R. Lewensohn, and J. Lehtio, "Affinity pre-fractionation for MS-based plasma proteomics," Proteomics, vol. 9, no. 6, pp. 1420-1427, 2009.
105. P. G. Righetti and E. Boschetti, "Sherlock Holmes and the proteome-a detective story," FEBS Journal, vol. 274, no. 4, pp. 897-905, 2007. (Pubitemid 46204410)
106. L. A. Liotta and E. F. Petricoin, "Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold," The Journal of Clinical Investigation, vol. 116, no. 1, pp. 26-30, 2006. (Pubitemid 43121786)
107. P. G. Righetti and E. Boschetti, "The ProteoMiner and the FortyNiners: searching for gold nuggets in the proteomic arena," Mass Spectrometry Reviews, vol. 27, no. 6, pp. 596-608, 2008.
108. A. Castagna, D. Cecconi, L. Sennels, et al., "Exploring the hidden human urinary proteome via ligand library beads," Journal of Proteome Research, vol. 4, no. 6, pp. 1917-1930, 2005. (Pubitemid 41814257)
109. L. Guerrier, S. Claverol, F. Fortis, et al., "Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries," Journal of Proteome Research, vol. 6, no. 11, pp. 4290-4303, 2007. (Pubitemid 350158505)
110. L. Sennels, M. Salek, L. Lomas, E. Boschetti, P. G. Righetti, and J. Rappsilber, "Proteomic analysis of human blood serum using peptide library beads," Journal of Proteome Research, vol. 6, no. 10, pp. 4055-4062, 2007. (Pubitemid 350032568)
111. V. Thulasiraman, S. Lin, L. Gheorghiu, et al., "Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands," Electrophoresis, vol. 26, no. 18, pp. 3561-3571, 2005. (Pubitemid 41410379)
112. J. Albrethsen, "Reproducibility in protein profiling by MALDI-TOF mass spectrometry," Clinical Chemistry, vol. 53, no. 5, pp. 852-858, 2007. (Pubitemid 46744240)
113. L. M. Preston, K. K. Murray, and D. H. Russell, "Repro-ducibility and quantitation of matrix-assisted laser desorp-tion ionization mass spectrometry: effects of nitrocellulose on peptide ion yields," Biological Mass Spectrometry, vol. 22, no. 9, pp. 544-550, 1993. (Pubitemid 23263438)
114. L. Ekblad, B. Baldetorp, M. Ferno, H. Olsson, and C. Bratt, "In-source decay causes artifacts in SELDI-TOF MS spectra," Journal of Proteome Research, vol. 6, no. 4, pp. 1609-1614, 2007. (Pubitemid 46724058)
115. D. A. Cairns, D. Thompson, D. N. Perkins, A. J. Stanley, P. J. Selby, and R. E. Banks, "Proteomic profiling using mass spectrometry-does normalising by total ion current potentially mask some biological differences?" Proteomics, vol. 8, no. 1, pp. 21-27, 2008.
116. W. Meuleman, J. Y. M. N. Engwegen, M.-C. W. Gast, J. H. Beijnen, M. J. T. Reinders, and L. F. A. Wessels, "Comparison of normalisation methods for surface-enhanced laser des-orption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data," BMC Bioinformatics, vol. 9, article 88, 2008.
117. W. Wegdam, P. D. Moerland, M. R. Buist, et al., "Classification- based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets," Proteome Science, vol. 7, p. 19, 2009.
118. N. Jeffries, "Algorithms for alignment of mass spectrometry proteomic data," Bioinformatics, vol. 21, no. 14, pp. 3066-3073, 2005. (Pubitemid 41418458)
119. C. S. Tan, A. Ploner, A. Quandt, J. Lehtio, and Y. Pawitan, "Finding regions of significance in SELDI measurements for identifying protein biomarkers," Bioinformatics, vol. 22, no. 12, pp. 1515-1523, 2006. (Pubitemid 43985324)
120. F. M. Smith, W. M. Gallagher, E. Fox, et al., "Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multi-modal neoadjuvant therapy," Annals of Surgery, vol. 245, no. 2, pp. 259-266, 2007. (Pubitemid 46151655)
121. P. Geurts, M. Fillet, D. de Seny, et al., "Proteomic mass spectra classification using decision tree based ensemble methods," Bioinformatics, vol. 21, no. 14, pp. 3138-3145, 2005. (Pubitemid 41418467)
122. S. Smit, H. C. J. Hoefsloot, and A. K. Smilde, "Statistical data processing in clinical proteomics," Journal of Chromatography B, vol. 866, no. 1-2, pp. 77-88, 2008. (Pubitemid 351491683)
123. E. T. Fung, T.-T. Yip, L. Lomas, et al., "Classification of cancer types by measuring variants of host response proteins using SELDI serum assays," International Journal of Cancer, vol. 115, no. 5, pp. 783-789, 2005. (Pubitemid 40776702)
124. J. Peng, A. J. Stanley, D. Cairns, P. J. Selby, and R. E. Banks, "Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles-initial evaluation using low molecular weight serum peaks," Proteomics, vol. 9, no. 2, pp. 492-498, 2009.
125. R. N. H. Pugh, I. M. Murray Lyon, J. L. Dawson, M. C. Pietroni, and R. Williams, "Transection of the oesophagus for bleeding oesophageal varices," British Journal of Surgery, vol. 60, no. 8, pp. 646-649, 1973.
126. L. Brugler, A. Stankovic, L. Bernstein, F. Scott, and J. O'Sullivan-Maillet, "The role of visceral protein markers in protein calorie malnutrition," Clinical Chemistry and Laboratory Medicine, vol. 40, no. 12, pp. 1360-1369, 2002. (Pubitemid 36024680)
127. P. B. Sehgal, "Interleukin-6: molecular pathophysiology," Journal of Investigative Dermatology, vol. 94, no. 6, supplement, pp. 2S-6S, 1990. (Pubitemid 20213060)
128. E. P. Diamandis, "Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?" Clinical Chemistry, vol. 49, no. 8, pp. 1272-1275, 2003. (Pubitemid 36900611)
129. N. Escher, M. Kaatz, C. Melle, et al., "Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides," Neoplasia, vol. 9, no. 3, pp. 254-259, 2007. (Pubitemid 46457242)
130. M. Ueda, Y. Misumi, M. Mizuguchi, et al., "SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy," Clinical Chemistry, vol. 55, no. 6, pp. 1223-1227, 2009.
131. L. Chen, S. Fatima, J. Peng, and X. Leng, "SELDI protein chip technology for the detection of serum biomarkers for liver disease," Protein and Peptide Letters, vol. 16, no. 5, pp. 467-472, 2009.
132. B. Matharoo-Ball, G. Ball, and R. Rees, "Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches-a prostate cancer perspective," Vaccine, vol. 25, supplement 2, pp. B110-B121, 2007. (Pubitemid 47488553)
133. A. Skytt, E. Thysell, P. Stattin, et al., "SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer," International Journal of Cancer, vol. 121, no. 3, pp. 615-620, 2007. (Pubitemid 46986495)
134. G. Xu, C. Q. Xiang, Y. Lu, et al., "Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma," Cancer Letters, vol. 282, no. 2, pp. 205-213, 2009.
135. B. J. McMorran, S. A. O. Patat, J. B. Carlin, et al., "Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients," Clinical Chemistry, vol. 53, no. 10, pp. 1782-1791, 2007. (Pubitemid 47509671)
136. C. Rocken, R. Ketterlinus, and M. P. A. Ebert, "Application of proteome analysis to the assessment of prognosis and response prediction in clinical oncology," Current Cancer Drug Targets, vol. 8, no. 2, pp. 141-145, 2008. (Pubitemid 351347250)
137. C. Trocme, H. Marotte, A. Baillet, et al., "Apolipoprotein A-I and